International Journal of Health Policy and Management

International Journal of Health Policy and Management

Colorectal Cancer Screening Programs: The Causal Effect of Their Organization and Testing Strategy on Participation

Document Type : Original Article

Authors
1 Faculty of Business Administration and Economics, FernUniversität in Hagen, Hagen, Germany
2 Health Economics and Policy Group, Institute for Social Policy, Department of Socioeconomics, Vienna University of Economics and Business, Vienna, Austria
Abstract
Background
Early detection of colorectal cancer (CRC) greatly increases the chances of cure, but participation in CRC screening programs remains low. The degree of organization and the testing method of these programs are key determinants of participation, yet causal evidence on how these program characteristics affect take-up remains scarce. Austria offers a unique setting to address this gap, with three co-existing CRC screening programs varying in organization and testing strategy across provinces. This paper estimates the causal effect of these three programs on screening participation to identify which program characteristics are most effective at increasing take-up.

Methods
We exploit regional and age-based variation in program eligibility, using claims data from a large Austrian public health insurer, and apply difference-in-differences (DD) and regression discontinuity (RD) methods to identify the programs’ causal effects.

Results
All three screening programs increase participation. The effect is strongest for the population-based program, which has the highest degree of organization and includes regular mailings of stool test kits. Participation in stool testbased screening increases by 30 percentage points (pp) on average among those aged 40 to 80 (DD) and by 20 pp at the age-40 eligibility cutoff (RD). The medium-organized program, which includes a quality assurance system and a guarantee of a qualified workforce, but offers colonoscopies without an invitation system, increases colonoscopy take-up by 0.8 pp on average (DD) and 1.2 pp at age 50 (RD). The low-organized program, where screening is offered within the annual general practitioner (GP) health checkup, increases participation by 12 pp for stool tests, and 0.5 pp for colonoscopies at age 50 (RD). Participation increases further when two programs co-exist.

Conclusion
Screening participation increases with the degree of organization of the screening program. Combining various program types could be beneficial in reaching larger shares of the target population.
Keywords

1.     World Health Organization (WHO). Global Cancer Burden Growing, Amidst Mounting Need for Services. WHO; 2024. https://www.who.int/news/item/01-02-2024-global-cancer-burden-growing--amidst-mounting-need-for-services.
2.     Kanavos P, Schurer W. The burden of colorectal cancer: prevention, treatment and quality of services. Eur J Health Econ. 2010;10 Suppl 1:S1-S3. doi:10.1007/s10198-009-0200-3
3.     Gini A, Jansen EE, Zielonke N, et al. Impact of colorectal cancer screening on cancer-specific mortality in Europe: a systematic review. Eur J Cancer. 2020;127:224-235. doi:10.1016/j.ejca.2019.12.014
4.     Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for colorectal cancer screening. Gastroenterology. 2020;158(2):418-432. doi:10.1053/j.gastro.2019.06.043
5.     Asaria M, Griffin S, Cookson R, Whyte S, Tappenden P. Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme. Health Econ. 2015;24(6):742-754. doi:10.1002/hec.3058
6.     Ran T, Cheng CY, Misselwitz B, Brenner H, Ubels J, Schlander M. Cost-effectiveness of colorectal cancer screening strategies-a systematic review. Clin Gastroenterol Hepatol. 2019;17(10):1969-1981.e1915. doi:10.1016/j.cgh.2019.01.014
7.     Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002-1013. doi:10.1016/s1470-2045(21)00199-6
8.     The Lancet Gastroenterology Hepatology. Improving uptake of colorectal cancer screening. Lancet Gastroenterol Hepatol. 2017;2(11):767. doi:10.1016/s2468-1253(17)30298-4
9.     OECD. Health at a Glance 2023: OECD Indicators. Paris: OECD Publishing; 2023. doi:10.1787/7a7afb35-en
10. Mosquera I, Mendizabal N, Martín U, Bacigalupe A, Aldasoro E, Portillo I. Inequalities in participation in colorectal cancer screening programmes: a systematic review. Eur J Public Health. 2020;30(3):416-425. doi:10.1093/eurpub/ckz236
11. Lin Y, Fan S, Chai W, et al. Barriers and facilitators to population participation in colorectal cancer screening: an umbrella review. BMC Health Serv Res. 2026;26(1). doi:10.1186/s12913-025-13879-z
12. Agunwamba AA, Zhu X, Sauver JS, Thompson G, Helmueller L, Finney Rutten LJ. Barriers and facilitators of colorectal cancer screening using the 5As framework: a systematic review of US studies. Prev Med Rep. 2023;35:102353. doi:10.1016/j.pmedr.2023.102353
13. Palmer CK, Thomas MC, von Wagner C, Raine R. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study. Br J Cancer. 2014;110(7):1705-1711. doi:10.1038/bjc.2014.125
14. Lo SH, Waller J, Wardle J, von Wagner C. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain. J Med Screen. 2013;20(2):73-79. doi:10.1177/0969141313492508
15. Zhang L, Carvalho AL, Mosquera I, et al. An international consensus on the essential and desirable criteria for an 'organized' cancer screening programme. BMC Med. 2022;20(1):101. doi:10.1186/s12916-022-02291-7
16. IARC. CanScreen5 - Glossary and Definitions. 2025. https://canscreen5.iarc.fr/?page=help.
17. Santare D, Kojalo I, Huttunen T, et al. Improving uptake of screening for colorectal cancer: a study on invitation strategies and different test kit use. Eur J Gastroenterol Hepatol. 2015;27(5):536-543. doi:10.1097/meg.0000000000000314
18. Sweet A, Lee D, Gairy K, Phiri D, Reason T, Lock K. The impact of CT colonography for colorectal cancer screening on the UK NHS: costs, healthcare resources and health outcomes. Appl Health Econ Health Policy. 2011;9(1):51-64. doi:10.2165/11588110-000000000-00000
19. Kim HB, Lee SM. When public health intervention is not successful: cost sharing, crowd-out, and selection in Korea's National Cancer Screening Program. J Health Econ. 2017;53:100-116. doi:10.1016/j.jhealeco.2017.02.006
20. Neter E, Stein N, Barnett-Griness O, Rennert G, Hagoel L. From the bench to public health: population-level implementation intentions in colorectal cancer screening. Am J Prev Med. 2014;46(3):273-280. doi:10.1016/j.amepre.2013.11.008
21. Tinmouth J, Patel J, Austin PC, et al. Increasing participation in colorectal cancer screening: results from a cluster randomized trial of directly mailed gFOBT kits to previous nonresponders. Int J Cancer. 2015;136(6):E697-E703. doi:10.1002/ijc.29191
22. Mehta SJ, Pepe RS, Gabler NB, et al. Effect of financial incentives on patient use of mailed colorectal cancer screening tests: a randomized clinical trial. JAMA Netw Open. 2019;2(3):e191156. doi:10.1001/jamanetworkopen.2019.1156
23. Bertoni M, Corazzini L, Robone S. The good outcome of bad news: a field experiment on formatting breast cancer screening invitation letters. Am J Health Econ. 2020;6(3):372-409. doi:10.1086/708930
24. Pilonis ND, Bugajski M, Wieszczy P, et al. Participation in competing strategies for colorectal cancer screening: a randomized health services study (PICCOLINO Study). Gastroenterology. 2021;160(4):1097-1105. doi:10.1053/j.gastro.2020.11.049
25. Carrieri V, Wuebker A. Quasi-experimental evidence on the effects of health information on preventive behaviour in Europe. Oxf Bull Econ Stat. 2016;78(6):765-791. doi:10.1111/obes.12134
26. Pletscher M. The effects of organized screening programs on the demand for mammography in Switzerland. Eur J Health Econ. 2017;18(5):649-665. doi:10.1007/s10198-016-0845-7
27. Buchmueller TC, Goldzahl L. The effect of organized breast cancer screening on mammography use: evidence from France. Health Econ. 2018;27(12):1963-1980. doi:10.1002/hec.3813
28. Carney P, O'Neill C. Income inequality in uptake of voluntary versus organised breast cancer screening: evidence from the British Household Panel Survey. BMC Public Health. 2018;18(1):252. doi:10.1186/s12889-018-5139-9
29. Eibich P, Goldzahl L. Health information provision, health knowledge and health behaviours: evidence from breast cancer screening. Soc Sci Med. 2020;265:113505. doi:10.1016/j.socscimed.2020.113505
30. Guthmuller S, Carrieri V, Wübker A. Effects of organized screening programs on breast cancer screening, incidence, and mortality in Europe. J Health Econ. 2023;92:102803. doi:10.1016/j.jhealeco.2023.102803
31. Francetic I, Meacock R, Sutton M. Understanding concordance in health behaviours among couples: evidence from the bowel cancer screening programme in England. J Econ Behav Organ. 2022;201:310-345. doi:10.1016/j.jebo.2022.08.001
32. Guthmuller S, Carrieri V, Wübker A. Direct and Indirect Effects of Cancer Screening Invitations on Participation in Europe: A Quasi-Experimental Analysis. Ruhr Economic Papers No. 1188. Essen: RWI - Leibniz-Institut für Wirtschaftsforschung; 2025. doi:10.4419/96973373
33. Bitler MP, Carpenter CS, Horn D. Effects of the colorectal cancer control program. Health Econ. 2021;30(11):2667-2685. doi:10.1002/hec.4397
34. Blair A, Gauvin L, Strumpf EC, Datta GD. Impact of organized colorectal cancer screening programs on screening uptake and screening inequalities: a study of systematic- and patient-reliant programs in Canada. J Cancer Policy. 2020;24:100229. doi:10.1016/j.jcpo.2020.100229
35. Calip GS, Meropol NJ, Weinberg DS. Colorectal cancer incidence among adults younger than 50 years-understanding findings from observational studies of lower gastrointestinal endoscopy. JAMA Oncol. 2022;8(7):981-983. doi:10.1001/jamaoncol.2022.0863
36. Dharwadkar P, Zaki TA, Murphy CC. Colorectal cancer in younger adults. Hematol Oncol Clin North Am. 2022;36(3):449-470. doi:10.1016/j.hoc.2022.02.005
37. Penz D, Waldmann E, Hackl M, et al. Colorectal cancer and precursor lesion prevalence in adults younger than 50 years without symptoms. JAMA Netw Open. 2023;6(12):e2334757. doi:10.1001/jamanetworkopen.2023.34757
38. Statistics Austria. Krebserkrankungen. https://www.statistik.at/statistiken/bevoelkerung-und-soziales/gesundheit/krebserkrankungen. Accessed June 24, 2026.
39. Statistics Austria. Around 409 000 people were living with cancer in Austria at the beginning of 2025. Press release 14 099-018/26. January 29, 2026. https://www.statistik.at/fileadmin/announcement/2026/01/20260129KrebsstatistikEN.pdf.
40. Fröschl B, Antony K, Ivansits S. Übersicht Nationaler Kolonkrebs-Screening-Programme (Overview of National Colon Cancer Screening Programmes). Wien: Gesundheit Österreich; 2017. https://jasmin.goeg.at/id/eprint/57.
41. Segnan N, Patnick J, von Karsa L. European Guidelines for Quality Assurance in Colorectal Cancer Screening and Diagnosis. Luxembourg: Publications Office of the European Union; 2010. doi:10.2772/1458
42. Hackl F, Halla M, Hummer M, Pruckner GJ. The effectiveness of health screening. Health Econ. 2015;24(8):913-935. doi:10.1002/hec.3072
43. Czypionka T, Fößleitner S, Koisser L, Riedel M, Röhrling G. Gastroenterologische und Hepatologische Versorgung in Österreich (Gastroenterological and Hepatological Care in Austria). Institut für Höhere Studien (IHS); 2022.
44. Füszl A, Eisenmann A, Piso B. Kurzübersicht zur Vorbereitung des Qualitätsstandards Vorsorgekoloskopie (Brief overview for the preparation of the quality standard for screening colonoscopy). Gesundheit Österreich; 2019.
45. Jonas, M. Volkswirtschaftlicher Nutzen eines Österreichischen Darmkrebsvorsorgep rogrammes – Berechnung auf Basis des Vorarlberger Vorsorgekoloskopie-P rogramms 2007–2015: Kosten- und Mortalitätssenkung durch qualitätsgesi cherte Koloskopie (Economic benefit of an Austrian colorectal cancer screening programme – calculation based on the Vorarlberg screening colonoscopy programme 2007–2015: cost and mortality reduction through quality-assured colonoscopy). Journal für Gastroenterologische und Hepatologische Erkrankungen. 2017;15:14-18.
46. BMASGK. Das österreichische Gesundheitssystem. Zahlen - Daten – Fakten (The Austrian healthcare system. Figures - Data – Facts). 2019.
47. ÖGK. Jahresbericht 2022 der Österreichischen Gesundheitskasse (ÖGK) (Annual Report 2022 of the Austrian Health Insurance Fund). 2022.
48. Abadie A, Athey S, Imbens GW, Wooldridge JM. When should you adjust standard errors for clustering? Q J Econ. 2023;138(1):1-35. doi:10.1093/qje/qjac038
49. Alkatout I, Biebl M, Momenimovahed Z, et al. Has COVID-19 affected cancer screening programs? A systematic review. Front Oncol. 2021;11:675038. doi:10.3389/fonc.2021.675038
50. Mani SS, Schut RA. The impact of the COVID-19 pandemic on inequalities in preventive health screenings: trends and implications for US population health. Soc Sci Med. 2023;328:116003. doi:10.1016/j.socscimed.2023.116003
51. Champion VL, Skinner CS. The health belief model. In: Health Behavior and Health Education: Theory, Research, and Practice. 4th ed. Jossey-Bass; 2008:45-65.
52. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Educ Res. 2003;18(2):156-170. doi:10.1093/her/18.2.156
53. Senore C, Giordano L, Bellisario C, Di Stefano F, Segnan N. Population based cancer screening programmes as a teachable moment for primary prevention interventions. A review of the literature. Front Oncol. 2012;2:45. doi:10.3389/fonc.2012.00045
54. O'Donoghue T, Rabin M. Doing it now or later. Am Econ Rev. 1999;89(1):103-124. doi:10.1257/aer.89.1.103
55. Peterson EB, Ostroff JS, DuHamel KN, et al. Impact of provider-patient communication on cancer screening adherence: A systematic review. Prev Med. 2016;93:96-105. doi:10.1016/j.ypmed.2016.09.034
56. Thaler RH, Sunstein CR. Nudge: Improving Decisions About Health, Wealth, and Happiness. Yale University Press, 2008
57. Ritvo P, Myers RE, Paszat L, Serenity M, Perez DF, Rabeneck L. Gender differences in attitudes impeding colorectal cancer screening. BMC Public Health. 2013;13:500. doi:10.1186/1471-2458-13-500
58. Priaulx J, Turnbull E, Heijnsdijk E, et al. The influence of health systems on breast, cervical and colorectal cancer screening: an overview of systematic reviews using health systems and implementation research frameworks. J Health Serv Res Policy. 2020;25(1):49-58. doi:10.1177/1355819619842314
59. Wools A, Dapper EA, Leeuw JD. Colorectal cancer screening participation: a systematic review. Eur J Public Health. 2016;26(1):158-168. doi:10.1093/eurpub/ckv148
60. Gingold-Belfer R, Leibovitzh H, Boltin D, et al. The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: a systematic review and meta-analysis. United European Gastroenterol J. 2019;7(3):424-448. doi:10.1177/2050640619828185
61. Mohl JT, Ciemins EL, Miller-Wilson LA, Gillen A, Luo R, Colangelo F. Rates of follow-up colonoscopy after a positive stool-based screening test result for colorectal cancer among health care organizations in the US, 2017-2020. JAMA Netw Open. 2023;6(1):e2251384. doi:10.1001/jamanetworkopen.2022.51384 

Articles in Press, Accepted Manuscript
Available Online from 16 November 2026

Supplementary File
(IJHPM does not take responsibility for any information provided in the supplementary files.)

  • Received Date 07 August 2025
  • Revised Date 08 October 2026
  • Accepted Date 01 November 2026
  • First Published Date 16 November 2026
  • Published Date 16 November 2026